Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says MHRA
UK’s regulatory authority will fast-track jabs modified to new variants
Read More
Tag: COVID-19 variant
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
